Met-enkephalin involvement in morphine-modulated peritonitis in swiss mice

Magdalena Chadzinska1, Anna Scislowska-Czarnecka, Krystyna Pierzchala-Koziec

  • 1Department of Evolutionary Immunobiology, Jagiellonian University, Kraków, Poland. chadz@zuk.iz.uj.edu.pl

Insights

Morphine co-administration with zymosan impacts Met-enkephalin (Met-ENK) levels during peritonitis. Coinjection with morphine enhanced Met-ENK in the peritoneal cavity while stabilizing brain levels, with effects lasting over seven days.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Zymosan-induced peritonitis in mice involves endogenous opioid systems.
  • Morphine's effects on pain and leukocyte accumulation are known.
  • Met-enkephalin (Met-ENK) is a key endogenous opioid peptide.

Purpose of the Study:

  • To investigate the impact of morphine and zymosan on Met-ENK levels.
  • To examine Met-ENK distribution in peritoneal fluid, leukocytes, and brain regions.
  • To understand the temporal effects of morphine on Met-ENK during inflammation.

Main Methods:

  • Swiss mice were injected with zymosan or zymosan plus morphine.
  • Leukocyte counts in peritoneal fluid were performed.
  • Met-ENK levels were measured in peritoneal fluid, leukocytes, striatum, hypothalamus, and pituitary gland.

Main Results:

  • Zymosan injection increased peritoneal fluid Met-ENK, decreasing it in leukocytes and brain regions.
  • Morphine coinjection boosted peritoneal Met-ENK accumulation and release from leukocytes.
  • Morphine inhibited early Met-ENK fluctuations in the hypothalamus and striatum.

Conclusions:

  • Morphine modulates Met-ENK dynamics during zymosan-induced peritonitis.
  • Coinjection with morphine alters Met-ENK distribution between the periphery and central nervous system.
  • The observed effects on the Met-ENK system persist for over seven days.

Related Concept Videos